A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts.

Jiaxing LinJieping YangXiao XuYutao WangMeng YuYuyan Zhu

Published in: Cancer cell international (2020)

The proposed 11-genes model is a promising biomarker for estimating overall survival in bladder cancer. This model can be used to stratify the risk of bladder cancer patients, which is beneficial to the realization of individualized treatment.

Keyphrases

end stage renal disease
ejection fraction
genome wide
newly diagnosed
prognostic factors
gene expression
free survival
dna methylation
genome wide identification
combination therapy
genome wide analysis